Quantitative washout in patients with hepatocellular carcinoma undergoing TACE: an imaging biomarker for predicting prognosis?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1470-7330
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Quantitative washout in patients with hepatocellular carcinoma undergoing TACE: an imaging biomarker for predicting prognosis? ; volume:22 ; number:1 ; day:11 ; month:1 ; year:2022 ; pages:1-11 ; date:12.2022
Cancer imaging ; 22, Heft 1 (11.1.2022), 1-11, 12.2022
- Creator
-
Müller, Lukas
Hahn, Felix
Jungmann, Florian
Mähringer-Kunz, Aline
Stoehr, Fabian
Halfmann, Moritz C.
Pinto dos Santos, Daniel
Hinrichs, Jan
Auer, Timo A.
Düber, Christoph
Klöckner, Roman Trutz
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40644-022-00446-6
- URN
-
urn:nbn:de:101:1-2022042520201184740392
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Müller, Lukas
- Hahn, Felix
- Jungmann, Florian
- Mähringer-Kunz, Aline
- Stoehr, Fabian
- Halfmann, Moritz C.
- Pinto dos Santos, Daniel
- Hinrichs, Jan
- Auer, Timo A.
- Düber, Christoph
- Klöckner, Roman Trutz
- SpringerLink (Online service)
Other Objects (12)
TACE versus TACE + entecavir versus TACE + tenofovir in the treatment of HBV associated hepatocellular carcinoma
Evaluation of models to predict prognosis in patients with advanced hepatocellular carcinoma treated with TACE combined with apatinib
Tace molesta tace fastidiosa diva
The impact of PD-1 inhibitors on prognosis in unresectable hepatocellular carcinoma treated with TACE and lenvatinib: a retrospective study
Biomarker in Hepatocellular Carcinoma
Efficacy, safety, and biomarker analysis of TACE combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a real-world study
Outcome of TACE treatment in HIV infected patients with hepatocellular carcinoma
TACE performed in patients with a single nodule of Hepatocellular Carcinoma
Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis
End-hole Versus Microvalve Infusion Catheters in Patients Undergoing Drug-Eluting Microspheres-TACE for Solitary Hepatocellular Carcinoma Tumors: A Retrospective Analysis
Transarterial chemoembolization (TACE) plus tyrosine kinase inhibitors versus TACE in patients with hepatocellular carcinoma: a systematic review and meta-analysis
Cortactin is a sensitive biomarker relative to the poor prognosis of human hepatocellular carcinoma
TACE versus TACE + entecavir versus TACE + tenofovir in the treatment of HBV associated hepatocellular carcinoma
Evaluation of models to predict prognosis in patients with advanced hepatocellular carcinoma treated with TACE combined with apatinib
Tace molesta tace fastidiosa diva
The impact of PD-1 inhibitors on prognosis in unresectable hepatocellular carcinoma treated with TACE and lenvatinib: a retrospective study
Biomarker in Hepatocellular Carcinoma
Efficacy, safety, and biomarker analysis of TACE combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a real-world study
Outcome of TACE treatment in HIV infected patients with hepatocellular carcinoma
TACE performed in patients with a single nodule of Hepatocellular Carcinoma
Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis
End-hole Versus Microvalve Infusion Catheters in Patients Undergoing Drug-Eluting Microspheres-TACE for Solitary Hepatocellular Carcinoma Tumors: A Retrospective Analysis
Transarterial chemoembolization (TACE) plus tyrosine kinase inhibitors versus TACE in patients with hepatocellular carcinoma: a systematic review and meta-analysis
Cortactin is a sensitive biomarker relative to the poor prognosis of human hepatocellular carcinoma
TACE versus TACE + entecavir versus TACE + tenofovir in the treatment of HBV associated hepatocellular carcinoma
Evaluation of models to predict prognosis in patients with advanced hepatocellular carcinoma treated with TACE combined with apatinib
Tace molesta tace fastidiosa diva
The impact of PD-1 inhibitors on prognosis in unresectable hepatocellular carcinoma treated with TACE and lenvatinib: a retrospective study
Biomarker in Hepatocellular Carcinoma
Efficacy, safety, and biomarker analysis of TACE combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a real-world study
Outcome of TACE treatment in HIV infected patients with hepatocellular carcinoma
TACE performed in patients with a single nodule of Hepatocellular Carcinoma
Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis
End-hole Versus Microvalve Infusion Catheters in Patients Undergoing Drug-Eluting Microspheres-TACE for Solitary Hepatocellular Carcinoma Tumors: A Retrospective Analysis
Transarterial chemoembolization (TACE) plus tyrosine kinase inhibitors versus TACE in patients with hepatocellular carcinoma: a systematic review and meta-analysis